𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinicopathologic markers of uterine leiomyosarcoma originating from smooth muscle tumors of low malignancy

✍ Scribed by K. Calsteren; M. Debiec-Rychter; P. Moerman; G. Tulunay; G. Verbist; S. Caluwaerts; L. Moons; I. Vergote; F. Amant

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
141 KB
Volume
1
Category
Article
ISSN
1613-3412

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular pathogenesis of uterine smooth
Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling
✍ Bradley J. Quade; Tao-Yeuan Wang; Kris Sornberger; Paola Dal Cin; George L. Mutt πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 241 KB πŸ‘ 1 views

## Abstract Uterine smooth muscle tumors range from the very common benign leiomyoma to the uncommon, but frequently lethal, leiomyosarcoma. Morphological and clinical differences between these tumors are presumed to result from differences in gene expression. To test this hypothesis, RNAs from fou

Malignant uterine smooth muscle tumors:
Malignant uterine smooth muscle tumors: Role of etoposide, cisplatin, and doxorubicin (EPA) chemotherapy
✍ Resnik, E.; Chambers, S. K.; Carcangiu, M. L.; Kohorn, E. I.; Schwartz, P. E.; C πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 287 KB

Background: Nearly 80% of patients with malignant uterine smooth muscle tumor will suffer local relapse and/or distant metastases after initial surgical resection. There is no convincing evidence that the addition of pelvic radiation improves the outcome. However, adjuvant chemotherapy might be an a